{ "model": { "rank": 4299, "code": "thing-q168800", "model_id": "vr.tr.anaphylaxis", "name": "anaphylaxis", "purpose": "Enable an agent to recognise a suspected anaphylaxis episode, track its clinical trajectory and support timely escalation, evidence capture and recurrence prevention.", "family": "Thing Registry", "category": "Information and virtual systems", "status": "research-draft", "kind": "thing", "plane": "INF", "domain": "INF.KNW", "industry": "", "version": "", "url": "/models/thing/q168800/", "tier": 2, "score": 76, "payload": { "layer": "wikidata", "aliases": [ "anaphylactic shock", "exercise-induced anaphylaxis", "pseudoanaphylaxis reaction", "food dependent exercise-induced anaphylaxis" ], "aliasCount": 4, "merged": 4, "knownIn": 76, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q168800", "url": "https://www.wikidata.org/wiki/Q168800", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T19:54:43Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 22.9, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087bb-90eb-7bb3-900d-f7090abb3101\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: anaphylaxis\nSense to describe: (none recorded)\nDomain code: XCT.STA\nAlso known as: (none)\n\n\nContext for this batch of 695 things:\n# Batch 004: 1001 regi", "usd": 0, "recall": true }, "codex": { "seconds": 72.4, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a087bb-90e1-7d13-8fc7-bb6cf5d7be87\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: anaphylaxis\nRegistry id: vr.tr.anaphylaxis\nPlane / domain: XCT / XCT.STA\nRegistry definition: (none recorded)\nNames folded into this entry: (none)\n\n\n" } } }, "metaModel": { "id": "THING-Q168800", "registryId": "vr.tr.anaphylaxis", "name": "anaphylaxis", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q168800/", "model": { "registry_id": "vr.tr.anaphylaxis", "name": "anaphylaxis", "purpose": "Enable an agent to recognise a suspected anaphylaxis episode, track its clinical trajectory and support timely escalation, evidence capture and recurrence prevention.", "definition": "Anaphylaxis is a serious systemic hypersensitivity reaction, usually rapid in onset, that may cause death through life-threatening airway, breathing or circulatory compromise and can occur without skin findings or shock.", "scope_statement": "This model owns anaphylaxis as an acute systemic hypersensitivity syndrome and its individual episodes under vr.tr.anaphylaxis, retaining XCT / XCT.STA while distinguishing the clinical condition from an abstract concept, underlying allergy and anaphylactic shock.", "in_scope": [ "Episode recognition using explicitly identified clinical criteria and diagnostic uncertainty", "Exposure chronology, suspected triggers and contributing cofactors", "Organ involvement, physiological deterioration and response to intervention", "Resolution, persistent symptoms and recurrence within the episode", "Episode-linked investigation, specialist assessment and prevention planning" ], "out_of_scope": [ "Allergic sensitisation and chronic allergy management beyond their relationship to an episode", "Isolated urticaria or local allergic reactions without anaphylaxis", "Independent models of asthma, vasovagal syncope and other diagnostic alternatives", "Drug formulation, prescribing rules and autoinjector engineering", "General shock, cardiac arrest and intensive-care management", "Underlying mast-cell disorders as independently managed conditions" ], "distinguishing_features": [ "Evaluate an acute clinical pattern against a named criteria set; an allergy label or exposure alone does not establish anaphylaxis.", "Skin findings are not mandatory: qualifying acute airway, respiratory or circulatory manifestations after a known or highly probable allergen can meet WAO criteria. [WAO guidance](https://pmc.ncbi.nlm.nih.gov/articles/7607509/)", "Isolated hives do not by themselves satisfy WAO anaphylaxis criteria; record associated organ involvement and exposure context. [WAO guidance](https://pmc.ncbi.nlm.nih.gov/articles/7607509/)", "Anaphylactic shock denotes circulatory failure associated with anaphylaxis; anaphylaxis does not require shock. [WAO guidance](https://pmc.ncbi.nlm.nih.gov/articles/7607509/)", "Separate the acute episode from continuing susceptibility: an individual may remain at risk after the episode resolves." ], "characteristics": [ { "name": "Diagnostic assessment", "kind": "state", "unit_or_values": "suspected | criteria-supported | uncertain | alternative diagnosis favoured; criteria authority, version and assessor", "why_it_matters": "Preserves the distinction between urgent working recognition and subsequent diagnostic review." }, { "name": "Exposure-to-onset interval", "kind": "measurement", "unit_or_values": "minutes or hours, with timestamp uncertainty and candidate exposure", "why_it_matters": "Supports causal assessment without assuming that the nearest exposure caused the episode." }, { "name": "Organ involvement", "kind": "category", "unit_or_values": "skin/mucosa | upper airway | lower respiratory | cardiovascular | gastrointestinal; present, absent or unassessed for each", "why_it_matters": "Makes the observed syndrome assessable against recognition criteria." }, { "name": "Physiological trajectory", "kind": "measurement", "unit_or_values": "blood pressure in mmHg, heart rate in beats/min, respiratory rate in breaths/min and oxygen saturation in %, each timestamped", "why_it_matters": "Supports assessment of deterioration and recovery with age, baseline and treatment context." }, { "name": "Trigger attribution", "kind": "relation", "unit_or_values": "episode linked to candidate food, medicine, venom, latex or other exposure; suspected, supported, excluded or unresolved", "why_it_matters": "Prevents a provisional trigger from becoming an unquestioned permanent allergy label." }, { "name": "Clinical course", "kind": "state", "unit_or_values": "evolving | improving | apparently resolved | persistent | recurrent; definitions and observation interval recorded", "why_it_matters": "Separates momentary improvement from the assessed course of the episode." }, { "name": "Intervention-response relationship", "kind": "relation", "unit_or_values": "intervention, administration time, dose and route where applicable, followed by timestamped observations", "why_it_matters": "Makes treatment history and apparent response reviewable without treating response as diagnostic proof." }, { "name": "Acute and baseline tryptase", "kind": "measurement", "unit_or_values": "ng/mL, sampling times relative to onset, assay reference information and paired baseline when available", "why_it_matters": "Supports investigation while preserving the limitation that normal tryptase does not exclude anaphylaxis. [WAO guidance](https://pmc.ncbi.nlm.nih.gov/articles/7607509/)" } ], "affordances": [ "Compare observed manifestations with a named anaphylaxis recognition framework and expose missing observations.", "Flag suspected anaphylaxis for immediate emergency escalation under the applicable clinical protocol.", "Construct a timeline connecting exposures, manifestations, interventions and subsequent changes.", "Track unresolved airway, breathing or circulation problems and route them to qualified responders.", "Prepare an episode handover that separates observations, reported history and causal hypotheses.", "Identify incomplete specialist referral, trigger investigation and personalised emergency-plan tasks." ] }, "sources": [], "structure": { "bundles": [ { "id": "syndrome-recognition", "name": "Syndrome recognition", "description": "Determine whether the observed episode supports anaphylaxis and make the basis of that judgement explicit.", "rationale": "Recognition depends on a clinical pattern, exposure context and the criteria used, rather than a single defining measurement.", "layers": [ { "id": "clinical-criteria", "name": "Clinical criteria", "description": "Represent the applicable definition and its mapping to observed manifestations.", "findings": [ { "id": "criteria-to-observation-match", "name": "Criteria-to-observation match", "description": "Record the criteria authority and version, each supporting observation and unresolved requirements; distinguish missing observations from negative findings.", "questions": [ { "text": "Which definition and diagnostic criteria are being applied, and for which clinical setting?", "kind": "definition", "id": "criteria-to-observation-match-q01" }, { "text": "Which timestamped manifestations support each criterion, including presentations without skin findings?", "kind": "measurement", "id": "criteria-to-observation-match-q02" } ] } ] }, { "id": "diagnostic-boundaries", "name": "Diagnostic boundaries", "description": "Keep anaphylaxis distinct from adjacent syndromes and narrower complications.", "findings": [ { "id": "alternatives-and-shock-status", "name": "Alternatives and shock status", "description": "Capture evidence for competing explanations and assess circulatory failure separately from the overall anaphylaxis judgement.", "questions": [ { "text": "What observations distinguish this episode from isolated urticaria, acute asthma, vasovagal syncope or a nonallergic cause of airway swelling?", "kind": "boundary", "id": "alternatives-and-shock-status-q01" }, { "text": "Is circulatory failure present, absent or unassessed, and what evidence supports that assessment?", "kind": "measurement", "id": "alternatives-and-shock-status-q02" } ] } ] } ] }, { "id": "exposure-and-causation", "name": "Exposure and causation", "description": "Connect the episode to possible elicitors without overstating causal certainty.", "rationale": "Emergency recognition and later trigger attribution are different judgements with different evidence requirements.", "layers": [ { "id": "exposure-chronology", "name": "Exposure chronology", "description": "Reconstruct relevant exposures and their timing relative to symptom onset.", "findings": [ { "id": "candidate-trigger-history", "name": "Candidate trigger history", "description": "Maintain competing exposure hypotheses, including route, amount when known, repeated administration and the reliability of reported times.", "questions": [ { "text": "Which foods, medicines, stings, materials or other exposures preceded onset, by what routes and at what times?", "kind": "provenance", "id": "candidate-trigger-history-q01" }, { "text": "Which timing details were directly recorded, recalled by the patient or inferred after the event?", "kind": "provenance", "id": "candidate-trigger-history-q02" } ] } ] }, { "id": "cofactors-and-attribution", "name": "Cofactors and attribution", "description": "Separate the suspected elicitor from contextual contributors and mechanism hypotheses.", "findings": [ { "id": "causal-confidence", "name": "Causal confidence", "description": "Record candidate cofactors and the evidence supporting trigger or mechanism assignments; preserve an unresolved cause when investigation is incomplete.", "questions": [ { "text": "Were exercise, alcohol, intercurrent illness or concurrent medicines present, and what supports a contributing role in this episode?", "kind": "provenance", "id": "causal-confidence-q01" }, { "text": "What evidence supports the attributed trigger and mechanism, and what investigation remains necessary before calling the episode idiopathic?", "kind": "boundary", "id": "causal-confidence-q02" } ] } ] } ] }, { "id": "severity-and-course", "name": "Severity and course", "description": "Represent organ compromise and its evolution across the episode.", "rationale": "A diagnostic label alone cannot indicate current danger, response or whether symptoms have returned.", "layers": [ { "id": "organ-compromise", "name": "Organ compromise", "description": "Track clinically meaningful manifestations and physiological trends.", "findings": [ { "id": "current-and-peak-severity", "name": "Current and peak severity", "description": "Keep current status, worst observed status and any formal severity grade distinct, with the grading framework identified.", "questions": [ { "text": "What are the current and worst recorded airway, respiratory and circulatory findings, interpreted against age and baseline?", "kind": "measurement", "id": "current-and-peak-severity-q01" }, { "text": "Which severity framework was used, and were observations obtained before or after treatment?", "kind": "provenance", "id": "current-and-peak-severity-q02" } ] } ] }, { "id": "persistence-and-recurrence", "name": "Persistence and recurrence", "description": "Describe the temporal course without prematurely assigning a recurrence subtype.", "findings": [ { "id": "resolution-and-return", "name": "Resolution and return", "description": "Record symptom resolution, any symptom-free interval and renewed symptoms alongside possible continued or repeated exposure.", "questions": [ { "text": "When did each manifestation resolve or return, and was complete resolution actually observed?", "kind": "measurement", "id": "resolution-and-return-q01" }, { "text": "Under the chosen definition, does renewed illness represent a biphasic reaction, persistent illness or a new exposure-associated episode?", "kind": "boundary", "id": "resolution-and-return-q02" } ] } ] } ] }, { "id": "emergency-response", "name": "Emergency response", "description": "Connect suspected anaphylaxis to emergency actions and assess their execution and effects.", "rationale": "The model must support time-sensitive escalation while leaving treatment authority and detailed regimens with applicable clinical protocols.", "layers": [ { "id": "initial-response", "name": "Initial response", "description": "Capture recognition, emergency activation and first-line treatment.", "findings": [ { "id": "recognition-to-treatment", "name": "Recognition-to-treatment", "description": "Intramuscular adrenaline is first-line treatment; record emergency activation and administration timing without making laboratory confirmation a prerequisite. [RCUK guideline](https://www.resus.org.uk/media/337/download)", "questions": [ { "text": "When was anaphylaxis suspected, when was emergency help activated and when was adrenaline administered?", "kind": "measurement", "id": "recognition-to-treatment-q01" }, { "text": "Which local protocol and responder role govern immediate treatment, positioning and transfer in this setting?", "kind": "action", "id": "recognition-to-treatment-q02" } ] } ] }, { "id": "response-and-escalation", "name": "Response and escalation", "description": "Connect reassessment to further qualified clinical intervention.", "findings": [ { "id": "ongoing-compromise", "name": "Ongoing compromise", "description": "Track persistent airway, breathing or circulation problems after treatment and identify protocol-defined escalation needs. Antihistamines do not replace adrenaline for these problems. [RCUK guideline](https://www.resus.org.uk/media/337/download)", "questions": [ { "text": "Which manifestations persist or worsen after each intervention, and when were they reassessed?", "kind": "measurement", "id": "ongoing-compromise-q01" }, { "text": "Does the response meet the applicable refractory-anaphylaxis criteria, and which qualified team must take over?", "kind": "action", "id": "ongoing-compromise-q02" } ] } ] } ] }, { "id": "investigation-and-future-protection", "name": "Investigation and future protection", "description": "Carry episode evidence into diagnostic review and a documented plan for future exposure.", "rationale": "Acute improvement does not settle causation or complete the work needed to reduce harm from another episode.", "layers": [ { "id": "diagnostic-evidence", "name": "Diagnostic evidence", "description": "Preserve the provenance and interpretation limits of episode-related investigations.", "findings": [ { "id": "laboratory-and-specialist-review", "name": "Laboratory and specialist review", "description": "Connect acute and baseline samples, subsequent allergy investigations and specialist conclusions to the original episode rather than replacing its clinical record.", "questions": [ { "text": "What samples were obtained, at what intervals from onset and resolution, and how were results interpreted using the relevant assay and guideline?", "kind": "measurement", "id": "laboratory-and-specialist-review-q01" }, { "text": "Which specialist conclusions support or revise the episode diagnosis and trigger attribution, and on what evidence?", "kind": "provenance", "id": "laboratory-and-specialist-review-q02" } ] } ] }, { "id": "observation-and-preparedness", "name": "Observation and preparedness", "description": "Record the rationale for disposition and completion of episode-linked prevention tasks.", "findings": [ { "id": "disposition-and-emergency-plan", "name": "Disposition and emergency plan", "description": "Document a risk-based observation decision, referral and personalised emergency preparedness, including prescribed rescue medication and training where indicated. [RCUK guideline](https://www.resus.org.uk/media/337/download)", "questions": [ { "text": "What episode features, treatment response and access to emergency care support the chosen observation and discharge plan?", "kind": "action", "id": "disposition-and-emergency-plan-q01" }, { "text": "Who will complete trigger review, avoidance advice, rescue-medication assessment and practical emergency-plan training?", "kind": "action", "id": "disposition-and-emergency-plan-q02" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This describes the clinical condition; no narrower registry sense was supplied.", "The kinds mix trigger categories with a clinical course category and are not mutually exclusive.", "Guideline editions, diagnostic criteria and jurisdiction-specific coding should be checked; these statements are recalled rather than source-verified." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Food-induced anaphylaxis", "Drug-induced anaphylaxis", "Insect-venom-induced anaphylaxis", "Exercise-induced anaphylaxis, including food-dependent exercise-induced anaphylaxis", "Idiopathic anaphylaxis", "Biphasic anaphylaxis" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "ICD-10", "value_or_pattern": "T78.2", "note": "Anaphylactic shock, unspecified; this is not a universal code for every anaphylaxis presentation, and trigger-specific categories also exist." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "World Allergy Organization anaphylaxis guidance: clinical recognition, diagnostic criteria and management.", "European Academy of Allergy and Clinical Immunology anaphylaxis guideline: diagnosis, treatment and prevention.", "Resuscitation Council UK guidance on emergency treatment of anaphylaxis." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Clinical recognition of a medical emergency requiring prompt intramuscular adrenaline, also called epinephrine.", "Allergy investigation to identify triggers and relevant cofactors.", "Individual emergency action plans and adrenaline auto-injector training.", "Documentation of severe hypersensitivity reactions in medical records and drug-safety reporting.", "Risk assessment for trigger avoidance and, where appropriate, venom immunotherapy." ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Delayed recognition because hives or other skin findings are absent.", "Progression to airway obstruction, respiratory failure, circulatory collapse or cardiac arrest.", "Delayed adrenaline administration or reliance on antihistamines as a substitute.", "Recurrence after apparent resolution without further exposure, termed a biphasic reaction.", "A normal serum tryptase result being incorrectly used to exclude anaphylaxis." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Adrenaline and epinephrine are regional names for the same medicine.", "Auto-injector availability, emergency-care access and prescribing arrangements vary between countries.", "Diagnostic coding and observation recommendations differ between national systems and guidelines." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Anaphylactic shock", "difference": "Anaphylactic shock is anaphylaxis with circulatory failure; anaphylaxis does not require shock." }, { "name": "Urticaria", "difference": "Isolated hives do not establish anaphylaxis; airway, breathing, circulatory or qualifying multisystem involvement distinguishes it." }, { "name": "Angioedema", "difference": "Angioedema is deeper tissue swelling that may occur within anaphylaxis or independently, including through bradykinin-mediated mechanisms." }, { "name": "Asthma exacerbation", "difference": "Asthma can cause bronchospasm without a systemic hypersensitivity reaction; exposure history and accompanying findings help distinguish it." }, { "name": "Vasovagal syncope", "difference": "Vasovagal syncope causes reflex fainting, often with pallor and bradycardia, rather than systemic hypersensitivity." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of anaphylaxis this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Which diagnostic frameworks should this catalogue support, and how should disagreements about gastrointestinal or isolated respiratory presentations be represented?", "Which severity, refractory-reaction and biphasic-reaction definitions should be adopted across community, emergency and perioperative settings?", "What age-specific and baseline-relative physiological thresholds should populate implementation rules, and who maintains their clinical validation?", "How should the model represent uncertainty in trigger attribution when exposure history, sensitisation tests and specialist conclusions disagree?", "Which jurisdiction-specific observation, referral and rescue-medication protocols should agents use, and how will their versions and review dates be maintained?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 18, "questions": 28 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "discipline or field of knowledge", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a anaphylaxis, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to recognise a suspected anaphylaxis episode, track its clinical trajectory and support timely escalation, evidence capture and recurrence prevention.", "characteristics": { "substance": "information", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "read and interpreted" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: anaphylactic shock, exercise-induced anaphylaxis, pseudoanaphylaxis reaction, food dependent exercise-induced anaphylaxis.", "4 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 76 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a anaphylaxis, and on what evidence are they told apart?" ], "whatItIsMadeOf": "content that has to be carried by something else", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "read it and act on what it says" ], "howItIsRecognised": [], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "anaphylactic shock", "exercise-induced anaphylaxis", "pseudoanaphylaxis reaction", "food dependent exercise-induced anaphylaxis" ] } ], "standing": "Described in 76 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 4 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one anaphylaxis from another, and a anaphylaxis from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a anaphylaxis sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a anaphylaxis from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a anaphylaxis passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a anaphylaxis between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a anaphylaxis, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a anaphylaxis is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "content-and-access", "name": "Content, encoding and access", "description": "What a anaphylaxis says, how it is encoded and who may read it.", "rationale": "An informational thing carries content that can be copied, versioned and withheld, none of which its physical carrier explains.", "layers": [ { "id": "content-and-encoding", "name": "Content and encoding", "description": "The content itself, its format and its language.", "findings": [ { "id": "content-and-format", "name": "Content, format and language", "description": "What a anaphylaxis contains and in what form it is held.", "questions": [ { "id": "content-and-format-q01", "text": "What identifies and describes the content of a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "content-and-format-q02", "text": "Who or what asserted this about the content of a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "content-and-format-q03", "text": "What may an agent decide or do once the content of a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "access-and-rights", "name": "Access, rights and retention", "description": "Who may read, copy or change it, and for how long it is kept.", "findings": [ { "id": "access-rules", "name": "Access rules and retention", "description": "The permissions attached to a anaphylaxis and the period it survives.", "questions": [ { "id": "access-rules-q01", "text": "What identifies and describes access to a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "access-rules-q02", "text": "Who or what asserted this about access to a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "access-rules-q03", "text": "What may an agent decide or do once access to a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "subject-and-method", "name": "Subject matter and method", "description": "What anaphylaxis studies and how it establishes anything.", "rationale": "A field is identified by its questions and its methods, and those are what distinguish it from the fields next to it.", "layers": [ { "id": "subject", "name": "Subject matter", "description": "The questions it takes as its own.", "findings": [ { "id": "subject-record", "name": "Questions and objects of study", "description": "What it is about, stated so a neighbouring field can be told apart.", "questions": [ { "id": "subject-record-q01", "text": "What questions and objects does anaphylaxis take as its own?", "kind": "definition" }, { "id": "subject-record-q02", "text": "Which questions does it share with a neighbouring field, and who claims them?", "kind": "boundary" } ] } ] }, { "id": "method", "name": "Method and evidence", "description": "How claims are established and what counts as evidence.", "findings": [ { "id": "method-record", "name": "Methods and standards of evidence", "description": "The methods used and what they are taken to establish.", "questions": [ { "id": "method-record-q01", "text": "By what methods does anaphylaxis establish claims, and what counts as sufficient evidence?", "kind": "provenance" }, { "id": "method-record-q02", "text": "What kind of claim can this field not settle, and where should an agent look instead?", "kind": "action" } ] } ] } ] }, { "id": "institutions-and-classification", "name": "Institutions and classification", "description": "Where anaphylaxis is practised and how catalogues place it.", "rationale": "The institutional footprint is the evidence that a field exists as a field rather than as a topic.", "layers": [ { "id": "institutions", "name": "Institutional markers", "description": "Societies, journals, degrees and departments.", "findings": [ { "id": "institution-record", "name": "Bodies and venues", "description": "Where the field organises itself.", "questions": [ { "id": "institution-record-q01", "text": "Which societies, journals or degrees mark anaphylaxis as an established field?", "kind": "provenance" }, { "id": "institution-record-q02", "text": "What would show that it is emerging or dissolving rather than established?", "kind": "boundary" } ] } ] }, { "id": "classification", "name": "Classification schemes", "description": "Where library and research classifications put it.", "findings": [ { "id": "classification-record", "name": "Codes and their disagreements", "description": "The classification codes that place it, and where they differ.", "questions": [ { "id": "classification-record-q01", "text": "Which classification schemes place anaphylaxis, under what codes?", "kind": "definition" }, { "id": "classification-record-q02", "text": "Where do those schemes disagree about its scope?", "kind": "boundary" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a anaphylaxis came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a anaphylaxis and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a anaphylaxis is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a anaphylaxis, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a anaphylaxis, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a anaphylaxis is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 6, "layers": 12, "findings": 14, "questions": 38 } } } }